We are live on
!
Find out more
LA
Lau Associates Portfolio holdings
AUM
$201M
1-Year Est. Return
26.29%
This Fund
S&P 500
This Quarter
Est. Return
+9.37%
1 Year Est. Return
+26.29%
3 Year Est. Return
+44.49%
5 Year Est. Return
+59.98%
10 Year Est. Return
–
AUM
$201M
AUM Growth
+$11.8M
(+6.3%)
Cap. Flow
+$1.1M
Cap. Flow
% of AUM
0.55%
Top 10 Holdings %
Top 10 Hldgs %
53.57%
Holding
99
New
3
Increased
6
Reduced
35
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$2.88M |
| 2 |
Novartis
NVS
|
+$561K |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$467K |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$219K |
| 5 |
Walt Disney
DIS
|
+$200K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Corteva
CTVA
|
+$643K |
| 2 |
TJX Companies
TJX
|
+$488K |
| 3 |
AbbVie
ABBV
|
+$473K |
| 4 |
Vanguard Dividend Appreciation ETF
VIG
|
+$471K |
| 5 |
CGC
Canopy Growth
CGC
|
+$318K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.92% |
| 2 | Healthcare | 11.95% |
| 3 | Consumer Staples | 8.61% |
| 4 | Energy | 8.58% |
| 5 | Financials | 5.88% |
No holdings matched the selected filter criteria.
Similar funds
JFM
SHA
AC
AEPI
TWM
QCM
IAM
VC
Lau Associates's Q4 2019 Portfolio in Review
As of Q4 2019, Lau Associates held 99 positions worth $201M, up 6.3% from $189M the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Lau Associates's Q4 2019 filing shows 3 new, 6 increased, 35 reduced and 5 closed positions. Its largest new stake was Vanguard FTSE Developed Markets ETF: 5,140 shares worth $226K. The largest sale was Corteva, an estimated $643K.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Staples.
- Lau Associates's largest Q4 2019 buy was Vanguard FTSE Developed Markets ETF: 5,140 shares worth $226K.
- Lau Associates added most to JPMorgan Ultra-Short Income ETF in Q4 2019, an estimated $2.88M increase.
- Lau Associates's biggest Q4 2019 reduction was Corteva, cutting an estimated $643K.
- Lau Associates fully exited AbbVie in Q4 2019, selling an estimated $473K.
- Lau Associates's ten largest holdings make up 54% of its $201M portfolio in Q4 2019.
- Lau Associates opened 3 new positions and closed 5 in Q4 2019.
- Lau Associates's portfolio value rose 6.3% quarter-over-quarter to $201M.
Based on Lau Associates's 13F filing for Q4 2019, filed 5 Feb 2020.